FLOTEC INC

FLOTEC INC specializes in precision manufacturing and advanced fabrication services within the medical device and instrumentation sector, as indicated by its primary NAICS code 339112. The company delivers high-tolerance components and assemblies requiring strict adherence to quality control standards, likely supporting regulated environments where repeatability, material integrity, and dimensional accuracy are critical. Technical expertise includes CNC machining, precision tooling, surface finishing, and assembly of complex electro-mechanical systems. While specific project details are not available, the nature of the NAICS classification suggests deep familiarity with regulatory frameworks such as ISO 13485 and FDA QSR, even without formal certifications on record. Differentiators likely include lean manufacturing practices, low-volume batch production agility, and the ability to support prototyping through full-scale production cycles for mission-critical medical hardware. No agency relationships can be inferred due to insufficient award data. Similarly, no recent contract history is available to characterize specific government partnerships or programmatic focus areas. The company’s industry focus centers on medical device manufacturing, encompassing the design and production of implants, diagnostic equipment components, and surgical instrumentation. This vertical requires rigorous process validation, traceability systems, and controlled environmental manufacturing—capabilities implied by the NAICS classification but not explicitly confirmed by awarded contracts. FLOTEC INC is structured as a small business under the 2L entity classification and is headquartered in Indianapolis, Indiana. The firm holds no formal government certifications such as 8(a), HUBZone, or WOSB. Its geographic presence is localized, with operations centered in the Midwest, positioning it as a regional supplier to federal and defense contractors requiring high-precision manufacturing support. Without public award history, its federal market footprint remains undefined, though its technical capabilities align with needs in biomedical and defense medical equipment supply chains.